Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome - Related Studies

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00017550. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Neoplasms
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		anti-thymocyte globulin

5	Additional drug interventions recognized in this trial
		Antilymphocyte Serum

6	More general drug interventions related to this trial
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Sangstat Medical Corporation